Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 34% ± 12% | |
peripheral blood | 17 studies | 41% ± 11% | |
brain | 17 studies | 30% ± 14% | |
intestine | 10 studies | 32% ± 16% | |
eye | 9 studies | 38% ± 15% | |
kidney | 8 studies | 30% ± 12% | |
liver | 6 studies | 41% ± 20% | |
lymph node | 5 studies | 36% ± 12% | |
bone marrow | 4 studies | 35% ± 12% | |
heart | 4 studies | 21% ± 5% | |
uterus | 4 studies | 44% ± 9% | |
breast | 4 studies | 36% ± 10% | |
prostate | 4 studies | 23% ± 3% | |
adipose | 4 studies | 27% ± 5% | |
pancreas | 3 studies | 40% ± 5% | |
placenta | 3 studies | 37% ± 12% | |
esophagus | 3 studies | 37% ± 26% | |
skin | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 11872.08 | 1445 / 1445 | 100% | 104.27 | 183 / 183 |
stomach | 100% | 9090.09 | 359 / 359 | 100% | 117.35 | 286 / 286 |
uterus | 100% | 14782.71 | 170 / 170 | 100% | 177.52 | 459 / 459 |
intestine | 100% | 12394.28 | 966 / 966 | 100% | 140.40 | 526 / 527 |
bladder | 100% | 12323.67 | 21 / 21 | 100% | 148.21 | 503 / 504 |
skin | 100% | 14497.21 | 1809 / 1809 | 100% | 142.93 | 471 / 472 |
pancreas | 100% | 6005.43 | 327 / 328 | 100% | 106.05 | 178 / 178 |
lung | 100% | 12621.97 | 577 / 578 | 100% | 120.45 | 1153 / 1155 |
brain | 100% | 8722.53 | 2636 / 2642 | 100% | 130.59 | 704 / 705 |
prostate | 100% | 11812.16 | 245 / 245 | 100% | 126.80 | 500 / 502 |
ovary | 100% | 15210.48 | 180 / 180 | 100% | 69.95 | 428 / 430 |
thymus | 100% | 13785.86 | 653 / 653 | 100% | 127.65 | 602 / 605 |
breast | 100% | 12826.82 | 459 / 459 | 99% | 149.93 | 1112 / 1118 |
liver | 100% | 6883.58 | 226 / 226 | 99% | 76.88 | 403 / 406 |
kidney | 100% | 9509.02 | 89 / 89 | 98% | 79.37 | 879 / 901 |
adrenal gland | 100% | 10021.78 | 258 / 258 | 95% | 81.45 | 219 / 230 |
adipose | 100% | 11987.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 11707.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 244.53 | 29 / 29 |
muscle | 100% | 9533.07 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 14771.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 198.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 66.06 | 1 / 1 |
heart | 99% | 7511.11 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 99.27 | 79 / 80 |
peripheral blood | 96% | 9055.40 | 895 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0042382 | Cellular component | paraspeckles |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005730 | Cellular component | nucleolus |
GO_0070062 | Cellular component | extracellular exosome |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0045202 | Cellular component | synapse |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HNRNPM |
Protein name | Heterogeneous nuclear ribonucleoprotein M (hnRNP M) Heterogeneous nuclear ribonucleoprotein M |
Synonyms | HNRPM NAGR1 |
Description | FUNCTION: Pre-mRNA binding protein in vivo, binds avidly to poly(G) and poly(U) RNA homopolymers in vitro. Involved in splicing. Acts as a receptor for carcinoembryonic antigen in Kupffer cells, may initiate a series of signaling events leading to tyrosine phosphorylation of proteins and induction of IL-1 alpha, IL-6, IL-10 and tumor necrosis factor alpha cytokines. |
Accessions | M0R0Y6 M0R019 ENST00000598367.5 M0QY96 ENST00000598999.1 M0QYQ7 M0R2I7 M0R0N3 P52272 ENST00000325495.9 [P52272-1] M0QZM1 ENST00000596295.1 ENST00000597270.1 ENST00000600806.5 M0R2T0 ENST00000594907.5 ENST00000601645.5 ENST00000348943.7 [P52272-2] ENST00000596984.5 M0QYL3 ENST00000600092.5 |